Strategic appointments support further growth and position Company for future successWESTLAKE VILLAGE, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) ...

Arcutis Biotherapeutics (ARQT) announced several promotions to support further growth of Arcutis and the ZORYVE portfolio. Patrick Burnett, MD, ...

The mean of analysts' price targets for Arcutis Biotherapeutics (ARQT) points to a 60.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ...

After hours: November 29 at 4:54 p.m. EST ...